Assess the current manufacturing landscape in the context of the COVID-19 pandemic. What are the short and long term implications for advanced therapeutics development?
Join advanced therapies stakeholders to take stock of the first half of 2020 and the short and long term implications of the ongoing COVID-19 pandemic. Hear an update on FDA regulatory guidance for manufacturers, take part in a virtual Q&A, and gain insight on current consortia initiatives and priorities for cell and gene therapy manufacturing and commercial development.
For more details: https://bit.ly/30e4GHG